Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: BJU Int. 2018 Apr 24;122(3):434–440. doi: 10.1111/bju.14220

Table 1.

Calculation of Pathologic Stage and 5-Year Overall Survival Outcomes Based on Established Clinical Stage Distribution in Muscle-Invasive Bladder Cancer

Pathological Stage Correction (%)
Clinical Stage (%) <T2N0 T2N0 T3N0 T4N0 TanyN+ 5-year OS (%)
cT2 (78.9) 22.7 22.2 29.5 3.5 22.1 56.1
cT3 (13.7) 16.3 6.3 50.1 3.3 24 51.3
cT4 (7.7) 0 4.1 10.1 32.8 53 39.6
5-year OS (%) 81 65 50 47 31